This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AAP BIDU DO LLL TSLA

Solarwinds (SWI) was downgraded at Needham to hold from buy. Company missed expectations and has several moving parts with the MSP acquisition, Needham said.

Tesla Motors (TSLA - Get Report) was upgraded at Deutsche Bank to buy from hold. $160 price target. Capitalizing on inherent advantages of electric vehicles, Deutsche Bank said.

Vantiv (VNTV) was upgraded at UBS to buy and given a $30 price target. Strong visibility and an attractive valuation, said UBS.

Vantiv (VNTV) was downgraded at Wells Fargo to market perform from outperform. Valuation call, as the company is seeing lower sales, Wells Fargo said.

Vertex Pharmaceuticals (VRTX) was downgraded at UBS to neutral and given a $83 price target. Safety concerns about VX-135, UBS said.

VCA Antech (WOOF) upgraded at Piper Jaffray to overweight from neutral. Price target was increased to $32. Favorable industry trends, improving margins, and upcoming buyback programs drive the bull case, Piper Jaffray said.

Zynga (ZNGA) was downgraded at Needham to hold from buy. Now expected to generate negative cash flow, Needham said.

Stock Comments / EPS Changes

Arch Capital Group (ACGL) numbers were raised at UBS. Estimates were raised to reflect the second-quarter earnings beat and the expectation of higher loss reserve releases, said UBS. Price target goes to $56.

Biogen Idec (BIIB) numbers were increased at BMO Capital. Estimates were boosted through 2014. Company continues to execute well with Tecfidera, BMO Capital said. Market Perform rating and new $237 price target.

BioMarin (BMRN) estimates were raised at UBS. Reflect the earnings beat, said UBS. Price target is $67.

Bristol-Myers (BMY) estimates were cut at UBS. Estimates were reduced given the voluntary OTC recalls and investments in the Eliquis launch, said UBS. Price target is $48.

Borg Warner (BWA) numbers were raised at Citigroup. Estimates were increased given margin expansion and potential for cash deployment, said Citigroup. Price target goes to $106.

Cameron International (CAM) estimates were cut at UBS. Estimates were reduced given integration delays with OneSubsea, said UBS. Price target is $75.

Chubb Corp. (CB) estimates were raised at UBS. Reflect the second-quarter beat and a decrease in the combined ratio outlook, said UBS. Price target is $96.
3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAP $148.74 0.00%
BIDU $175.22 0.00%
DO $23.67 0.00%
LLL $135.75 0.00%
TSLA $211.53 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs